Championing ESG as a Growth Driver amid Political & Regulatory Shifts

In 2025, ESG professionals in life sciences face more complexity and more pressure than ever before. Political headwinds in the U.S., reporting rollbacks in Europe, and increasing scrutiny from stakeholders have made ESG initiatives an increasingly polarized area of the business. However, amid shifting priorities and blurred regulatory boundaries, one thing remains constant: the undeniable value of ESG as a driver of innovation, resilience, and positive impact across business, people, patients, and the planet.

At a time when resources are tighter, internal alignment is harder to secure, and Scope 3 emissions and decarbonization remain persistent challenges, the 4th ESG in Life Sciences Summit East returns as the industry’s most trusted and practical forum for sustainability leaders in pharma, biotech, medtech, and life sciences services.

Whether you're working to build internal buy-in, align sustainability with commercial goals, strengthen supplier collaboration, or navigate emerging reporting expectations, this summit is designed to meet you where you are - and help you move forward.

Built with expert insights from both industry giants and SMEs, the 2025 agenda will tackle your most pressing challenges head-on. From reporting strategy and stakeholder engagement to supply chain optimization and climate risk management, you’ll leave with the insights and tools you need to keep ESG a central pillar of long-term success - even in the face of uncertainty.